Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Mandelboim

Showing results (1-10 of 231) with videos related to

Pageof 24
Sort By:
Frontiers in Immunology|January 31, 2014
The role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetesJonatan Enk, Ofer Mandelboim
Frontiers in Immunology|September 27, 2018
NKG2D Ligands-Critical Targets for Cancer Immune Escape and TherapyDominik Schmiedel, Ofer Mandelboim
Seminars in Immunopathology|September 20, 2014
The use of microRNA by human viruses: lessons from NK cells and HCMV infectionTal Goldberger, Ofer Mandelboim
Seminars in Immunopathology|October 16, 2014
Editorial introduction for Seminars in Immunopathology special issue on "immune modulation, properties and models of CMV"Tal Goldberger, Ofer Mandelboim
Cell Metabolism|August 9, 2018
Sweet Killers: NK Cells Need Glycolysis to Kill TumorsBatya Isaacson, Ofer Mandelboim
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2025
Engineered chemokines, resistant to cancer-mediated post-transcriptional modifications, as drugs to improve cancer immunotherapyOfer Mandelboim, Angel Porgador
RNA Biology|May 24, 2012
Battle of the midgets: innate microRNA networkingShlomo Elias, Ofer Mandelboim
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 9, 2010
The unique properties of uterine NK cellsIrit Manaster, Ofer Mandelboim
Frontiers in Immunology|April 27, 2017
Disarming Cellular Alarm Systems-Manipulation of Stress-Induced NKG2D Ligands by Human HerpesvirusesDominik Schmiedel, Ofer Mandelboim
Cancer Immunology, Immunotherapy : CII|October 14, 2019
Natural killer cells control metastasis via structural editing of primary tumors in miceBatya Isaacson, Ofer Mandelboim
Pageof 24

Showing results (1-10 of 231) with videos related to

Sort By:
Pageof 24
Frontiers in Immunology|January 31, 2014
The role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetesJonatan Enk, Ofer Mandelboim
Frontiers in Immunology|September 27, 2018
NKG2D Ligands-Critical Targets for Cancer Immune Escape and TherapyDominik Schmiedel, Ofer Mandelboim
Seminars in Immunopathology|September 20, 2014
The use of microRNA by human viruses: lessons from NK cells and HCMV infectionTal Goldberger, Ofer Mandelboim
Seminars in Immunopathology|October 16, 2014
Editorial introduction for Seminars in Immunopathology special issue on "immune modulation, properties and models of CMV"Tal Goldberger, Ofer Mandelboim
Cell Metabolism|August 9, 2018
Sweet Killers: NK Cells Need Glycolysis to Kill TumorsBatya Isaacson, Ofer Mandelboim
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2025
Engineered chemokines, resistant to cancer-mediated post-transcriptional modifications, as drugs to improve cancer immunotherapyOfer Mandelboim, Angel Porgador
RNA Biology|May 24, 2012
Battle of the midgets: innate microRNA networkingShlomo Elias, Ofer Mandelboim
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|January 9, 2010
The unique properties of uterine NK cellsIrit Manaster, Ofer Mandelboim
Frontiers in Immunology|April 27, 2017
Disarming Cellular Alarm Systems-Manipulation of Stress-Induced NKG2D Ligands by Human HerpesvirusesDominik Schmiedel, Ofer Mandelboim
Cancer Immunology, Immunotherapy : CII|October 14, 2019
Natural killer cells control metastasis via structural editing of primary tumors in miceBatya Isaacson, Ofer Mandelboim
Pageof 24